Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
Federal Trade Commission
Fish and Richardson
US Army
Dow
Covington
Moodys
Medtronic

Generated: October 20, 2018

DrugPatentWatch Database Preview

Alprostadil - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for alprostadil and what is the scope of alprostadil patent protection?

Alprostadil is the generic ingredient in six branded drugs marketed by Teva Pharms Usa, West-ward Pharms Int, Pfizer, Pharmacia And Upjohn, Auxilium Pharms Llc, and Mylan Speciality Lp, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for alprostadil. Five suppliers are listed for this compound.

Medical Subject Heading (MeSH) Categories for alprostadil
Synonyms for alprostadil
(-)-Protaglandin E1
(11?,13E,15S)-11,15-Dihydroxy-9-oxo-prost-13-en-1-oic acid
(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid
(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid
(13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid
(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate
(1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid
119314-69-1
11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid
22299-37-2
3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid
50-83-9
50865-30-0
7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid
7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid
7-[(1r,3r)-3-Hydroxy-2-[(1e,3s)-3-Hydroxyoct-1-En-1-Yl]-5-Oxocyclopentyl]heptanoic Acid
7-[5-((1E)(3S)-3-hydroxyoct-1-enyl)(1R,4R,5R)-4-hydroxy-2-oxocyclopentyl]hepta noic acid
745-65-3
745P653
9-oxo-11R,15S-dihydroxy-13E-prostaenoic acid
AB0014134
AB00514004
AB00514004_09
AB00514004-06
AB00514004-08
AB2000131
AC-6095
AC1NQXHQ
AI3-62116
AKOS015961103
Alista
Alprostadil (JP15/USP/INN)
Alprostadil (JP17/USP/INN)
Alprostadil [USAN:USP:INN:BAN:JAN]
Alprostadil, European Pharmacopoeia (EP) Reference Standard
Alprostadil, meets USP testing specifications
Alprostadil, United States Pharmacopeia (USP) Reference Standard
Alprostadil(Caverject)
Alprostadilum
Alprostadilum [INN-Latin]
Alprox-TD
AS-16360
B2154
BC205461
BCP9000277
BDBM50101853
Befar
Befar (TN)
BG0025
BIDD:GT0747
BML1-F06
BPBio1_001293
BRD-K52459643-001-06-0
BSPBio_001175
BSPBio_001488
C04741
CAS-745-65-3
Caverject
Caverject (TN)
Caverject Impulse
CCG-101188
CHEBI:15544
CHEMBL495
CPD000112594
CS-1905
Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)-
Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l-
D00180
D0I4DQ
D0N2EF
DR001827
DSSTox_CID_2578
DSSTox_GSID_22578
DSSTox_RID_76640
DTXSID9022578
Edex
Edex (TN)
EINECS 212-017-2
EX-A1411
F5TD010360
FemLife
Femprox
GMVPRGQOIOIIMI-DWKJAMRDSA-N
GTPL1882
HEI-507
HMS1361K10
HMS1571K17
HMS1791K10
HMS1989K10
HMS2052L11
HMS2090L08
HMS2098K17
HMS3268I09
HMS3402K10
HMS3648O17
HY-B0131
IDI1_033958
K274
l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid
l-PGE1
l-Prostaglandin E1
Lipo-alprostadil
Lipoprost
Liprostin
LMFA03010134
LP069786
MFCD00077860
Minprog
MLS000758964
MLS001424250
MolPort-003-939-183
MR 256
MR-256
Muse
Muse (TN)
NC00438
NCGC00016535-01
NCGC00025234-02
NCGC00025234-03
NCGC00025234-04
NCGC00025234-05
NSC 165559
ONO 1608
PGE-1
PGE1
PGE1 Oligomer
PGE1;Prostaglandin E1
PGE1alpha
Prestwick2_001018
Prestwick3_001018
Prink (TN)
Promostan
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11.alpha.,13E,15S)-
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-
Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer
Prostaglandin E1
Prostaglandin E1, >=98% (HPLC), synthetic
Prostaglandin E1, >=99.0% (TLC)
Prostaglandin E1, powder, gamma-irradiated, BioXtra, suitable for cell culture
Prostaglandin E1, synthetic, powder, BioReagent, suitable for cell culture
Prostaglandin E1;Edex;Muse;Liprostin;Caverject
Prostaglandin-E1
Prostaglandine E
ProstaglandinE1
Prostandin
Prostavasin
Prostin VR
Prostin VR Pediatric
Prostin VR pediatric (TN)
Prostivas
RayVa
RP17688
RTECS HK5096000
s1508
SAM001246840
SAM001246845
SAM001247093
SCHEMBL33317
SMP2_000271
SMR000112594
SR-01000946253
SR-01000946253-1
ST50826271
Sugiran
SYN3025
Topiglan
Tox21_110482
U 10136
U-10,136
U-10136
UNII-F5TD010360
Vasaprostan
Viridal
Vitaros
Vitaros (TN)
W-104416
XPG
ZINC3813088

US Patents and Regulatory Information for alprostadil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-003 Jun 12, 1997 AP RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-001 Jun 12, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-001 Jul 6, 1995 AP RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-001 Jun 11, 2002 RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Teva Pharms Usa ALPROSTADIL alprostadil INJECTABLE;INJECTION 075196-001 Apr 30, 1999 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for alprostadil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-004 Nov 19, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-002 Jul 6, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-004 Nov 19, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-001 Nov 19, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Speciality Lp MUSE alprostadil SUPPOSITORY;URETHRAL 020700-001 Nov 19, 1996 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
US Department of Justice
Federal Trade Commission
Fish and Richardson
US Army
Dow
Covington
Moodys
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.